课题基金 / 基金详情

Peroxynitrite in Cardiac Ischemia/Reperfusion Injury

Peroxynitrite in Cardiac Ischemia/Reperfusion Injury
过氧亚硝酸盐在心脏缺血/再灌注损伤中的作用
批准号:
6537715
负责人:
XIN-LIANG MA
金额:
$27.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-10 至 2004-05-31

项目摘要

项目成果

XIN-LIANG MA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nitro-compounds (e.g., nitroglycerin), as exogenous NO donors, have been used to treat MI for over one hundred years. The benefits of NO- treatment in reperfusion, however, have recently been challenged. Biochemical evidence reveals that ONOO-, the reaction product of NO with O2, is a highly reactive moiety that causes tissue damage comparable to that caused by OH Although these in vitra studies support a role for ONOO- in myocardial reperfusion injury, extension of these observations to relevant whole organs or to in viva models is lacking. More importantly, recent studies suggest that the effects of ONOO- are critically dependent on the microenvironment in which this oxidant is produced. The long-term goal of this project is to enhance the understanding of ONOO- in reperfusion injury. In specific aim number 1, chemically-synthesized ONOO- will be continually infused into the left atrium of rabbits at various doses and intervals during coronary occlusion or reperfusion. The effects of this exogenous ONOO- on infarct size, cardiac function, and PMN accumulation will be evaluated in a clinically relevant in vivo model. In specific aim number 2, endogenous ONOO- will be inhibited by administration of superoxide, nitric oxide, or ONOO- scavenger. The role of endogenously formed ONOO- in reperfusion will be evaluated and different strategies aimed at decreasing ONOO- concentration to a level that protects against reperfusion injury will be studied- In specific aim number3, the mechanisms by which ONOO- influences PMN-EC interactions will be determined in isolated rabbit neutrophils and cultured rabbit microvascular endothelial cells. The proposed studies are clinically relevant because the results may alter future treatment of cardiac ischemia. The studies outlined in this proposal are fundamental to understanding the role of NO in ischemia-reperfusion injury, and are prerequisite to clinical trials designed to decrease reperfusion injury through the manipulation of NO production.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cav-3 in Diabetic Myocardial Injury Following Ischemia/Reperfusion
  • 批准号:
    10317046
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2015
  • 负责人:
    XIN-LIANG MA
  • 依托单位:
Cav-3 in Diabetic Myocardial Injury Following Ischemia/Reperfusion
  • 批准号:
    10063885
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2015
  • 负责人:
    XIN-LIANG MA
  • 依托单位:
Cav-3 in Diabetic Myocardial Injury Following Ischemia/Reperfusion
  • 批准号:
    8886391
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2015
  • 负责人:
    XIN-LIANG MA
  • 依托单位:
Cav-3 in Diabetic Myocardial Injury Following Ischemia/Reperfusion
  • 批准号:
    10534136
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2015
  • 负责人:
    XIN-LIANG MA
  • 依托单位:
海外基金